We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
To stay alive, the patient will need to undergo long-term dialysis or receive a kidney transplant. Currently more than 600,000 patients in China had access to dialysis, but the estimated ESRD prevalence is much higher.
With the worldwide demand for dialysis projected to more than double by 2030, and with most of that growth coming from Asia1, there is an urgent need for health care professionals to access education that can advance their dialysis knowledge and skills.
Unicyte AG, a pioneering leader in human liver stem cells and nano-extracellular vesicles, announced today the formation of its inaugural Scientific Advisory Board with the appointments of Professors Giovanni Camussi, Camillo Ricordi and Paul Robbins.